Novoa, A., Quispe, R., Vargas, J., Morales, D., De, M. (2019). Responsabilidad social empresarial en el sector farmacéutico peruano [Tesis, Pontificia Universidad Católica del Perú]. http://hdl.handle.net/20.500.12404/14698
Novoa, A., Quispe, R., Vargas, J., Morales, D., De, M. Responsabilidad social empresarial en el sector farmacéutico peruano [Tesis]. PE: Pontificia Universidad Católica del Perú; 2019. http://hdl.handle.net/20.500.12404/14698
title = "Responsabilidad social empresarial en el sector farmacéutico peruano",
author = "De La Cruz Humbo, Máximo",
publisher = "Pontificia Universidad Católica del Perú",
year = "2019"
Nowadays, the Corporate Social Responsibility (CSR) has become worldwide more common than it was 20 or 30 years ago. Certainly in our country it has also become more important in recent years. The pharmaceutical sector is associated with ethical, social issues, and products that directly influence the life and the health of people, becoming the most debated and criticized global industry. In Peru we do not have an updated CSR diagnosis in the pharmaceutical sector that is why this research tries to diagnose the state of the corporate social responsibility in the pharmaceutical industry of Peru, and develop strategies for its improvement. In this study participated 10 pharmaceutical companies, and the survey "Social Responsibility in the Peruvian Pharmaceutical Industry" was used as an adapted tool based on the publication of CSR indicators of Peru 2021. The priority stakeholders to attend were chosen based on the survey results, and with the four models of strategic prioritization. Improvement proposals were planned from strengths and weaknesses identified in the survey of CSR in the pharmaceutical sector. The priority of the improvement proposals was made by assessing the social and economic impact, and the feasibility of implementation. The Peruvian pharmaceutical industry obtained a final average score of 2.58 on a scale of 4. The investigation shows that the stakeholders with lower scores are community, environment, and employees. The strategies proposed are focused on increasing the final average of CSR obtained in the first diagnosis. Finally, it is noted that CSR in Peruvian pharmaceutical industry is at an early stage, and in some stakeholders, is not perceived.
This item is licensed under a Creative Commons License